0G8X

Immunovia Ab (publ) News

Kaufen
Verkaufen
Best deals to access real time data!
Real-time Level 1 for London Stock Exchange
Monthly Subscription
for only
22,17 €
Real-time Level 2 for London Stock Exchange
Monthly Subscription
for only
59,13 €
GOLD TRADER
Monthly Subscription
for only
121,88 €
VAT not included
Name Symbol Markt Aktientyp ISIN Beschreibung
Immunovia Ab (publ) 0G8X London Ordinary Share SE0006091997 IMMUNOVIA ORD SHS
  Änderung Änderung % Aktuell Zeit
0,00 0,0% 191,40 01:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
191,40 191,40
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.11.202017:44PRNUSChief Executive Officer, Patrik Dahlen Buys Immunovia Shares
17.11.202017:38PRNUSChief Executive Officer, Patrik Dahlen Buys Immunovia Shares
12.11.202016:18PRNUSImmunovia Reports Third Quarter Interim Report January -..
12.11.202016:16PRNUSImmunovia Reports Third Quarter Interim Report January -..
11.11.202004:01PRNUSNomination Committee appointed for the 2021 Annual General..
11.11.202003:58PRNUSNomination Committee appointed for the 2021 Annual General..
06.11.202008:53PRNUSInvitation to Presentation of Immunovia´s Interim Report..
06.11.202008:49PRNUSInvitation to Presentation of Immunovia´s Interim Report..
02.11.202020:31PRNUSImmunovia Provides Complementary Details on the IMMray™..
02.11.202020:30PRNUSImmunovia Provides Complementary Details on the IMMray™..
30.10.202009:57PRNUSChange in the Number of Shares and Votes in Immunovia AB..
30.10.202009:56PRNUSChange in the Number of Shares and Votes in Immunovia AB..
28.10.202008:50PRNUSImmunovia to Host Webinar Introducing New CEO, Patrik Dahlen
28.10.202008:47PRNUSImmunovia to Host Webinar Introducing New CEO, Patrik Dahlen
27.10.202016:00PRNUSImmunovia Provides Complementary Information on the IMMray™..
27.10.202015:58PRNUSImmunovia Provides Complementary Information on the IMMray™..
26.10.202016:12PRNUSImmunovia Announces Completion of Analysis from the IMMray™..
26.10.202016:11PRNUSImmunovia Announces Completion of Analysis from the IMMray™..
29.9.202009:10PRNUSImmunovia Announces Positive Results from the IMMray™..
29.9.202009:06PRNUSImmunovia Announces Positive Results from the IMMray™..
23.9.202016:48PRNUSSummary from The Extraordinary General Meeting of Immunovia
23.9.202016:46PRNUSSummary from The Extraordinary General Meeting of Immunovia
02.9.202008:49PRNUSImmunovia Announces Management Team Changes
02.9.202008:48PRNUSImmunovia Announces Management Team Changes
31.8.202008:47PRNUSNotice of Extraordinary General Meeting in Immunovia AB
31.8.202008:45PRNUSNotice of Extraordinary General Meeting in Immunovia AB
28.8.202009:18PRNUSRegistration Details for Immunovia's Second Webinar in the..
28.8.202009:16PRNUSRegistration Details for Immunovia's Second Webinar in the..
26.8.202008:46PRNUSImmunovia Announces CEO Transition: Appoints Patrik Dahlen..
26.8.202008:45PRNUSImmunovia Announces CEO Transition: Appoints Patrik Dahlen..
20.8.202016:39PRNUSImmunovia Reports Second Quarter Interim Report January -..
20.8.202016:33PRNUSImmunovia Reports Second Quarter Interim Report January -..
18.8.202009:15PRNUSImmunovia to Host a Second Webinar in the Series on IMMray™..
18.8.202009:13PRNUSImmunovia to Host a Second Webinar in the Series on IMMray™..
13.8.202008:19PRNUSInvitation to presentation of Immunovia's interim report..
13.8.202008:16PRNUSInvitation to presentation of Immunovia's interim report..
30.6.202009:18PRNUSChange in the Number of Shares and Votes in Immunovia AB..
30.6.202009:16PRNUSChange in the Number of Shares and Votes in Immunovia AB..
30.6.202009:10PRNUSImmunovia Targeting Long-Term Market Penetration of 30% for..
30.6.202009:07PRNUSImmunovia Targeting Long-Term Market Penetration of 30% for..
29.6.202017:11PRNUSImmunovia to Present a Satellite Symposium at the European..
29.6.202017:10PRNUSImmunovia to Present a Satellite Symposium at the European..
26.6.202015:25PRNUSRegistration Details for Immunovia's Virtual Investor Day on..
26.6.202015:20PRNUSRegistration Details for Immunovia's Virtual Investor Day on..
26.6.202009:49PRNUSImmunovia Expands its Lung Cancer Program Based on..
26.6.202009:29PRNUSImmunovia Expands its Lung Cancer Program Based on..
15.6.202017:43PRNUSImmunovia to Host Virtual Investor Day on Tuesday, June 30,..
15.6.202017:40PRNUSImmunovia to Host Virtual Investor Day on Tuesday, June 30,..
09.6.202018:22PRNUSImmunovia Raised ~ 400m SEK to Further Accelerate the Market..
09.6.202018:21PRNUSImmunovia Raised ~ 400m SEK to Further Accelerate the Market..
Mehr News über diese Aktie »
Kürzlich von Ihnen besucht
LSE
0G8X
Immunovia ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

P: V: D:20201124 06:24:26